Zanolimumab, a fully human monoclonal antibody: Preliminary results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphomas (PTCL)

Francesco d'Amore; Thomas Relander; Mats Jerkeman; Hans Hagberg; Anders Osterborg; Peter Johnson; John A. Radford; Barry W. Hancock; Martin Gramatzki; Norbert Schmitz; Herve Tilly; Franck Morschhauser; Steen Lisby; Ole Baadsgaard

Zanolimumab, a fully human monoclonal antibody: Preliminary results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphomas (PTCL)

Francesco d'Amore, Thomas Relander, Mats Jerkeman, Hans Hagberg, Anders Osterborg, Peter Johnson, John A. Radford, Barry W. Hancock, Martin Gramatzki, Norbert Schmitz, Herve Tilly, Franck Morschhauser, Steen Lisby, Ole Baadsgaard

Department of Chemistry

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	Undefined
Pages (from-to)	770A-770A
Number of pages	1
Journal	Blood
Volume	108
Issue number	11
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

d'Amore, F., Relander, T., Jerkeman, M., Hagberg, H., Osterborg, A., Johnson, P., Radford, J. A., Hancock, B. W., Gramatzki, M., Schmitz, N., Tilly, H., Morschhauser, F., Lisby, S., & Baadsgaard, O. (2006). Zanolimumab, a fully human monoclonal antibody: Preliminary results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphomas (PTCL). Blood, 108(11), 770A-770A.

@article{2aa3acc0ef234adcae847d9379fc47d9,

title = "Zanolimumab, a fully human monoclonal antibody: Preliminary results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphomas (PTCL)",

author = "Francesco d'Amore and Thomas Relander and Mats Jerkeman and Hans Hagberg and Anders Osterborg and Peter Johnson and Radford, {John A.} and Hancock, {Barry W.} and Martin Gramatzki and Norbert Schmitz and Herve Tilly and Franck Morschhauser and Steen Lisby and Ole Baadsgaard",

year = "2006",

language = "Undefined",

volume = "108",

pages = "770A--770A",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "11",

}

d'Amore, F, Relander, T, Jerkeman, M, Hagberg, H, Osterborg, A, Johnson, P, Radford, JA, Hancock, BW, Gramatzki, M, Schmitz, N, Tilly, H, Morschhauser, F, Lisby, S & Baadsgaard, O 2006, 'Zanolimumab, a fully human monoclonal antibody: Preliminary results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphomas (PTCL)', Blood, vol. 108, no. 11, pp. 770A-770A.

TY - JOUR

T1 - Zanolimumab, a fully human monoclonal antibody

T2 - Preliminary results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphomas (PTCL)

AU - d'Amore, Francesco

AU - Relander, Thomas

AU - Jerkeman, Mats

AU - Hagberg, Hans

AU - Osterborg, Anders

AU - Johnson, Peter

AU - Radford, John A.

AU - Hancock, Barry W.

AU - Gramatzki, Martin

AU - Schmitz, Norbert

AU - Tilly, Herve

AU - Morschhauser, Franck

AU - Lisby, Steen

AU - Baadsgaard, Ole

PY - 2006

Y1 - 2006

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000242440003512&KeyUID=WOS:000242440003512

M3 - Meeting Abstract

SN - 0006-4971

VL - 108

SP - 770A-770A

JO - Blood

JF - Blood

IS - 11

ER -

Zanolimumab, a fully human monoclonal antibody: Preliminary results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphomas (PTCL)

UN SDGs

Other files and links

Cite this